Stem Cells Spin S.A. (WSE: SCS)
Health Care · Biotechnology · PL
zł0.44
-10.20% today · +4.8% 1Y
Stem Cells Spin S.A. (WSE: SCS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.68M.
Over the last twelve months the share price has gained 4.8%, trading between 0.28 and 0.54.
Tweenvest scores Stem Cells Spin S.A. across four factors: quality 61/100, value 36/100, growth 34/100. Its strongest factor is quality.
SCS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.68M
- Revenue (TTM)
- $15.54K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- zł0.54
- 52-week low
- zł0.28
- Avg volume (3M)
- —
- Shares outstanding
- 41.34M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Plant Advanced Technologies SAENXTPA: ALPAT | $4.96M | €3.94 | -1.01% |
| genXone S.A.WSE: GX1 | $4.90M | zł5.76 | -2.37% |
| Creative Medical Technology Holdings, Inc.NasdaqCM: CELZ | $4.89M | $0.74 | -11.63% |
| bioAffinity Technologies, Inc.NasdaqCM: BIAF | $4.79M | $3.73 | -21.06% |
| AFC Agro Biotech LimitedDSE: AFCAGRO | $4.67M | Tk5.00 | -12.28% |
| Xenetic Biosciences, Inc.NasdaqCM: XBIO | $4.66M | $1.99 | -6.57% |
| Vectus Biosystems LimitedASX: VBS | $4.54M | AU$0.11 | -4.55% |
| Bharat Immunologicals & Biologicals Corporation LimitedBSE: 524663 | $4.51M | Rs9.91 | +13.52% |
Figures last refreshed Oct 18, 2026.